Management of platinum-sensitive recurrent ovarian cancer (PSROC) in the era of biologics: Can ASCO’s net health benefits (NHB) inform our decisions?

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Foote, J; Havrilesky, LJ; Jewell, EL; Gamble, C; Ehrisman, J; Broadwater, G; Coleman, RL; Cohn, DE; Secord, AA

Published Date

  • May 20, 2017

Published In

Volume / Issue

  • 35 / 15_suppl

Start / End Page

  • 5544 - 5544

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2017.35.15_suppl.5544